Pharmacokinetic and pharmacodynamic properties of biapenem, a carbapenem antibiotic, in rat experimental model of severe acute pancreatitis

Pancreas

Volumn 36, Issue 2, 2008, Pages 125-132

  Muto, Yuko ^a   Mikami, Yukio ^b   Sakakibara, Shiro ^a   Shimizu, Atsuyuki ^a   Niida, Masashi ^a   Kataoka, Hiroshi ^a   Ito, Fumi ^a   Suzuki, Katsuyoshi ^a   Kijima, Koji ^a   Maebashi, Kazunori ^a   Takata, Toshihiko ^a   Hikida, Muneo ^a   Takeda, Kazunori ^c   Unno, Michiaki ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Biapenem; Carbapenem; Imipenem; Pancreatic concentration; Severe acute pancreatitis

Indexed keywords

BIAPENEM; CILASTATIN; IMIPENEM; TAUROCHOLIC ACID; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COUNT; BACTERIUM DETECTION; CONTROLLED STUDY; CORYNEBACTERIUM; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG PENETRATION; ENTEROCOCCUS; ESCHERICHIA; EXPERIMENTAL MODEL; INFECTION COMPLICATION; INFECTION RISK; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS; ACUTE DISEASE; ANIMAL; ASCITES; BACTERIAL INFECTION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; HOSPITALIZATION; INTESTINE; LYMPH NODE; METABOLISM; MICROBIOLOGY; PANCREAS; PANCREATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; ASCITES; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIPENEM; INJECTIONS, SUBCUTANEOUS; INTESTINES; LYMPH NODES; MALE; PANCREAS; PANCREATITIS; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TAUROCHOLIC ACID; THIENAMYCINS;

EID: 45549091028     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181568ed7     Document Type: Article

References (38)

1. Sekimoto M, Takada T, Kawarada Y, et al. JPN guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:10-24.
2. Ranson JHC. The current management of acute pancreatitis. Adv Surg. 1995;28:93-112.
3. Beger HG, Krautzberger W, Bittner R, et al. Results of surgical treatment of necrotizing pancreatitis. World J Surg. 1985;9:972-979.
4. Beger HG, Bittner R, Block S, et al. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986;91:433-438.
5. Takeda K, Takada T, Kawarada Y, et al. JPN guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13:42-47.
6. Mayumi T, Takada T, Kawarada Y, et al. Management strategy for acute pancreatitis in the JPN guidelines. J Hepatobiliary Pancreat Surg. 2006;13:61-67.
7. Büchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bacterial antibiotics. Gastroenterology. 1992;103: 1902-1908.
8. Bassi C, Pederzoli P, Vesentini S, et al. Behavior of antibiotics during human necrotizing pancreatitis. Antimicrob Agents Chemother. 1994;38: 830-836.
9. Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993; 176:480-483.
10. Malanoski GJ, Collins L, Wennersten C, et al. In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 1993;37:2009-2016.
11. Raymond NJ, Bremner DA. The in-vitro activity of biapenem against 964 clinical isolates of aerobic bacteria. J Antimicrob Chemother. 1995; 35:681-686.
12. Aldridge KE, Morice N, Schiro DD. In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes. Antimicrob Agents Chemother. 1994;38:889-893.
13. Bonfiglio G, Maccarone G, Mezzatesta ML, et al. In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates. Chemotherapy. 1997;43:393.
14. Perry CM, Ibbotson T. Biapenem. Drugs. 2002;62:2221-2234.
15. Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Scand J Gastroenterol. 1980;15:411-416.
16. Yamashita N, Kawashima K, Nomura K, et al. Pharmacokinetics of biapenem in laboratory animals. Chemotherapy. 1994;42:243-250. [In Japanese].
17. Foxx-Orenstein A, Orenstein R. Antibiotics and pancreatitis. Gastroenterologist. 1997;5:157-164.
18. Schmid SW, Uhl W, Friess H, et al. The role of infection in acute pancreatitis. Gut. 1999;45:311-316.
19. Dervenis C, Smailis D, Hatzitheoklitos E. Bacterial translocation and its prevention in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2003;10:415-418.
20. Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet. 1995;346:663-667.
21. Schwartz M, Isenmann R, Meyer H, et al. Antibiotic use in necrotizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr. 1997;122:356-361.
22. Moyshenyat I, Mandell E, Tenner S. Antibiotic prophylaxis of pancreatic infection in patients with necrotizing pancreatitis: rationale, evidence, and recommendations. Curr Gastroenterol Rep. 2006;8:121-126.
23. Heinrich S, Schafer M, Rousson V, et al. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006; 243:154-168.
24. Foitzik T, Ferna'ndez-del Castillo C, Ferraro MJ, et al. Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg. 1995;222:179-185.
25. Mithö fer K, Ferna'ndez-del Castillo C, Ferraro MJ, et al. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology. 1996;110:232-240.
26. Foitzik T, Hotz HG, Kinzig M, et al. Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis. Gut. 1997;40:526-530.
27. Naruse S, Wang Y, Kitagawa M, et al. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. Pancreas. 2000;21:290-295.
28. Hikida M, Kawashima K, Yoshida M, et al. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex. J Antimicrob Chemother. 1992;30:129-134.
29. Hikida M, Kawashima K, Nishiki K, et al. Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic. Antimicrob Agents Chemother. 1992;36:481-483.
30. Brismar B, A° kerlund J-E, Sjö stedt S, et al. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group. Scand J Infect Dis. 1996;28:507-512.
31. Kawada K, Deguchi T, Tsukamoto T, et al. Comparative study on biapenem and imipenem/cilastatin in complicated urinary tract infections. Chemotherapy. 2000;48:218-232. [In Japanese].
32. Isenmann R, Beger HG. Bacterial infection of pancreatic necrosis: role of bacterial translocation, impact of antibiotic treatment. Pancreatology. 2001;1:79-89.
33. Kashitani F, Fukuzawa S, Mori C, et al. In vitro activities of carbapenem antibiotics against the various clinical isolates. Jpn J Antibiot. 2000;53:1-25. [In Japanese].
34. Yamaguchi K, Ishii Y, Iwata M, et al. Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2004. Jpn J Antibiot. 2005;58:655-689. [In Japanese].
35. Tanimura H, Kawaguchi T, Murakami K, et al. Tissue concentrations and clinical efficacy of biapenem in surgical infections. Chemotherapy. 1994;42 S-4:523-534. [In Japanese].
36. Yokoyama T, Kodama T, Takesue Y, et al. Basic and clinical studies of biapenem in the surgical field. Chemotherapy. 1994;42 S-4:549-558. [In Japanese].
37. Foitzik T, Mithö fer K, Ferraro MJ, et al. Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis. Ann Surg. 1994;220: 193-198.
38. Mikami Y, Takeda K, Shibuya K, et al. Peritoneal inflammatory cells in acute pancreatitis: relationship of infiltration dynamics and cytokine production with severity of illness. Surgery. 2002;132: 86-92.